Clinical Trial Update: Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color） [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (Neo-Color) is evaluating radiotherapy plus systemic therapy as conversion therapy for patients with pMMR/MSS T4M0 colon cancer, and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Colon Cancer | Phase 2 | Status: RECRUITING